Cytokinetics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Cytokinetics
Tip: Access up to 7 years of quarterly data
All positions including Cytokinetics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytokinetics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $271M | 3.2M | 83.49 |
| 2023-09-30 | $30M | 1.0M | 29.46 |
| 2023-06-30 | $35M | 1.1M | 32.62 |
| 2023-03-31 | $41M | 1.2M | 35.19 |
| 2022-12-31 | $51M | 1.1M | 45.82 |
| 2022-03-31 | $17M | 463k | 36.81 |
| 2021-12-31 | $6.8M | 149k | 45.58 |
| 2021-09-30 | $1.1M | 30k | 35.75 |
| 2021-06-30 | $563k | 28k | 19.80 |
| 2021-03-31 | $632k | 27k | 23.25 |
| 2020-12-31 | $489k | 24k | 20.79 |
| 2020-09-30 | $14M | 660k | 21.65 |
| 2017-12-31 | $3.5M | 427k | 8.15 |
| 2013-09-30 | $11M | 1.4M | 7.59 |
| 2013-06-30 | $17M | 1.5M | 11.57 |